Quick Answer
Elevance Health, Inc. reported Total Revenue of $199.12 billion for fiscal year 2025.
Elevance Health, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $199.12B | +12.5% |
| 2024 | $177.01B | +3.3% |
| 2023 | $171.34B | +9.4% |
| 2022 | $156.59B | +13.0% |
| 2021 | $138.64B | +13.8% |
| 2020 | $121.87B | +16.9% |
| 2019 | $104.21B | +13.1% |
| 2018 | $92.11B | +2.3% |
| 2017 | $90.04B | +6.1% |
| 2016 | $84.86B | +7.2% |
| 2015 | $79.16B | +7.2% |
| 2014 | $73.87B | +4.0% |
| 2013 | $71.02B | +15.5% |
| 2012 | $61.50B | +1.3% |
| 2011 | $60.71B | +3.4% |
| 2010 | $58.70B | -9.6% |
| 2009 | $64.94B | +6.0% |
| 2008 | $61.25B | +0.1% |
| 2007 | $61.17B | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $50.71B | +12.4% | +1.9% |
| June 30, 2025 | $49.78B | +13.4% | +1.8% |
| March 31, 2025 | $48.89B | +14.8% | +8.4% |
| September 30, 2024 | $45.11B | +5.3% | +2.8% |
| June 30, 2024 | $43.89B | +0.5% | +3.1% |
| March 31, 2024 | $42.58B | +1.0% | -0.6% |
| September 30, 2023 | $42.85B | +7.3% | -1.9% |
| June 30, 2023 | $43.67B | +13.0% | +3.6% |
- Elevance Health, Inc. showed an increase of +12.5% in Total Revenue compared to the prior fiscal year.
- Over the 2007–2025 period, Elevance Health, Inc.’s total revenue has grown by 225.5% (from $61.17 billion to $199.12 billion).
- The most recent figure is from Elevance Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: